What Fueled Hospital Acquired Infections Testing Kits Market?
The hospital acquired infections testing kits market has seen considerable growth due to a variety of factors.
• In the past few years, there has been a marked increase in the market size of testing kits for hospital-acquired infections. The market is projected to expand, rising from $4.54 billion in 2024 to $4.83 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%.
Factors leading to this growth in the historical period include higher instances of hospital-acquired infections (HAIs), an aging population, and a rise in the number of surgeries.
What Can Be Expected from the Hospital Acquired Infections Testing Kits Market in the Coming Years?
The hospital acquired infections testing kits market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust expansion in the market for hospital acquired infections testing kits in the coming years. The market is set to reach a value of $6.78 billion by 2029, propelled by a compound annual growth rate (CAGR) of 8.8%.
The upswing projected in the forecast period is linked to factors like the growing prevalence of chronic illnesses, escalating healthcare spending and amplified government backing. Significant trends for the forecast period encompass alliances with artificial intelligence firms, securing assistance from the government, incorporating big data in market assessments, and forming partnerships with other market participants.
What Are The Essential Drivers Behind The Growth Of The Hospital Acquired Infections Testing Kits Market?
Both inpatients and outpatients are increasingly being impacted by hospital-acquired infections (HAIs), also referred to as nosocomial infections. These are illnesses that patients acquire during their stay in healthcare facilities such as hospitals and clinics. For instance, the Center for Disease Control and Prevention has reported that roughly 1.7 million individuals in the United States contract HAIs when admitted for different health complications, and a staggering 5% (over 98,000) of these patients ultimately succumb to these infections. The growing prevalence of HAIs is subsequently driving an increased demand for testing kits in the hospital-acquired infections market.
How Are The Segments Defined Within The Global Hospital Acquired Infections Testing Kits Market?
The hospital acquired infections testing kits market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)
Pre-Book The Hospital Acquired Infections Testing Kits Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Hospital Acquired Infections Testing Kits Market Landscape?
Technological advancements in diagnostic tests used for identifying HAIs, like flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies, are presenting more precise data. An exemplary growth can be noticed in the functioning of mass spectrometers, which are responsible for quantifying known substances and discovering unrecognized compounds within a specimen. An example would be the X500 QTOF from SCIEX, a compact device still delivering high resolution and precision. It quickly provides test results, accelerating the process of making data-driven judgments.
Who Are the Key Players in the Hospital Acquired Infections Testing Kits Market?
Major companies operating in the hospital acquired infections testing kits market include:
• Becton
• Dickinson and Company
• Abbott Laboratories
• Cepheid
• F. Hoffmann-La Roche Ltd
• Hologic. Inc
• STERIS plc
• QIAGEN
• Meridian Bioscience Inc.
• BioMérieux SA
• Metall Zug (Belimed Group)
• Innovaccer
• JD Health
• CISCO Systems Inc
• GE Healthcare
• Honeywell Lifesciences
• Zydus Cadila
• ImmunoScience
• CPC Diagnostics
• Seegene
• SD Biosensor
• Vivacheck Lab
• Fujirebio
• Sysmex Corporation
• Philip Healthcare
• Getein Biotech
• Hangzhou Biotest Biotech
• AmonMed Biotechnology
• Beijing Tigsun Diagnostics
• Hunan Lituo Biotechnology
• Bayer AG
• Cantel Medical Corporation
• Siemens Healthineers
What Is The Most Dominant Region In The Hospital Acquired Infections Testing Kits Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
